TTY Biopharm Co (ROCO:4105) Other Operating Expense: NT$-0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4105 TTY Biopharm Co Ltd ROCO:4105
85 GF Score
Price NT$77.80
GF Value NT$87.68
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is TTY Biopharm Co Other Operating Expense?

TTY Biopharm Co ROCO:4105 -0.13% 85 Other Operating Expense is NT$-0 Mil as of Jun. 2026. GuruFocus rates ROCO:4105 with a GF Score™ of 85/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 1 warning sign investors should review.

TTY Biopharm Co's Other Operating Expense for the three months ended in Jun. 2026 was NT$-0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-0 Mil.

TTY Biopharm Co's quarterly Other Operating Expense stayed the same from Dec. 2025 (NT$0 Mil) to Mar. 2026 (NT$0 Mil) but then declined from Mar. 2026 (NT$0 Mil) to Jun. 2026 (NT$-0 Mil).

TTY Biopharm Co's annual Other Operating Expense declined from Dec. 2023 (NT$0 Mil) to Dec. 2024 (NT$0 Mil) but then increased from Dec. 2024 (NT$0 Mil) to Dec. 2025 (NT$0 Mil).

TTY Biopharm Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for TTY Biopharm Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTY Biopharm Co Other Operating Expense Chart

TTY Biopharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TTY Biopharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 -0.00
ROCO:4105
85GF Score
TTY Biopharm Co Ltd ROCO:4105
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTY Biopharm Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of NT$-0 Mil mean?
TTY Biopharm Co (ROCO:4105) has a Other Operating Expense of NT$-0 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on TTY Biopharm Co and its competitors.
Is TTY Biopharm Co's Other Operating Expense too high?
TTY Biopharm Co's current Other Operating Expense is NT$-0 Mil. Overall, TTY Biopharm Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTY Biopharm Co's Other Operating Expense compare to ZTS?
TTY Biopharm Co's Other Operating Expense of NT$-0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on TTY Biopharm Co and its competitors. TTY Biopharm Co's current Other Operating Expense is NT$-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTY Biopharm Co stock overvalued right now?
Based on GuruFocus' analysis, TTY Biopharm Co (ROCO:4105) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$77.80 — trading 11.3% below its estimated fair value. The current Other Operating Expense is NT$-0 Mil. TTY Biopharm Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For TTY Biopharm Co (ROCO:4105), the current Other Operating Expense is NT$-0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTY Biopharm Co (ROCO:4105) Overvalued in 2026?

Based on GuruFocus' analysis, TTY Biopharm Co stock appears to be undervalued. The current stock price of NT$77.80 is trading 11.3% below its estimated GF Value™ of NT$87.68. GuruFocus considers TTY Biopharm Co to be Modestly Undervalued.

Key valuation signals for ROCO:4105:

  • Other Operating Expense: NT$-0 Mil
  • GF Value™: NT$87.68 vs. price of NT$77.80 (11.3% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TTY Biopharm Co Business Description

Address No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in America. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.
85GF Score

Get the complete analysis for ROCO:4105

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$77.80
Price
NT$87.68
GF Value